RPRX250117C27500
- 3.40
- 0.000.00%
Royalty Pharma Newsroom
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
Cytokinetics Started at Buy by Stifel, Aficamten Highlighted
4 Stocks With Growth Potential That Recently Announced Dividend Hikes
Royalty Pharma Plc's (NASDAQ:RPRX) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Royalty Pharma Plc (RPRX): Analysts Recommend This 52-Week High Stocks Now
TD Cowen Maintains Royalty Pharma(RPRX.US) With Buy Rating, Maintains Target Price $42
TD Cowen Initiates Royalty Pharma(RPRX.US) With Buy Rating, Announces Target Price $42
Royalty Pharma Announces 2024 Achievements and Strategic Plans
U.S. Stock Market Insights | Delta Air Lines has scored big! Stock prices hit a new high, with performance and outlook both exceeding expectations; a $16.4 billion acquisition of Calpine, Energy giant CEG surged by 25.16%.
The Medical merger and acquisition frenzy has started again! It is rumored that Johnson & Johnson is in talks to acquire the biopharmaceutical company Intra-Cellular Therapies Inc., which focuses on treating central nervous system diseases, and its stock price has soared nearly 15%.
Royalty Pharma (NASDAQ:RPRX) Has Announced That It Will Be Increasing Its Dividend To $0.22
Walgreens Boots Alliance, Aurora Innovation And Delta Air Lines Are Among Top Large Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?
Did Royalty Pharma (RPRX) Close Shortened Trading Week Higher?
Royalty Pharma To Go Ex-Dividend On February 21st, 2025 With 0.22 USD Dividend Per Share
January 10th (Eastern Time) - $Royalty Pharma(RPRX.US)$ is trading ex-dividend on February 21st, 2025.Shareholders of record on February 21st, 2025 will receive 0.22 USD dividend per share on March 10
Update: Royalty Pharma to Acquire RP Management, Approves $3 Billion Share Buyback; Shares Rise
TD Synnex, Walgreens, Savers Value Village And Other Big Stocks Moving Higher On Friday
Royalty Pharma Up Nearly 8%, on Pace for Largest Percent Increase Since February 2024 -- Data Talk
Sector Update: Health Care Stocks Decline Premarket Friday
Royalty Pharma Shares Are Trading Higher After the Company Announced It Increased Its Quarterly Dividend.
Royalty Pharma to Simplify Corporate Structure in $1.1B Deal for External Manager
Express News | Royalty Pharma Shares up 5.8% Premarket After Co Simplifies Corporate Structure With $1.1 Bln Deal